Jubilant Pharmova Limited
Web: jubl.com NSE: JUBLPHARMA BSE: 530019 SECTOR: Healthcare - Pharmaceuticals & Biotechnology
990 5(0%)
Volume
1L as on 26, May
Open
1,206
High
1,096
Low
1,068
Close
985
VWAP
992
52 Week High
1,248
52 Week Low
786
Quality Score
00/00
Growth Score
00/00
Valuation Score
00/00
Momentum Score
00/00
Analyst Recommendations
BUY/SELL
|
|
Analyst Price Target
-
Market Cap (cr)
15,771
No. of Shares
P/E
622.93
P/B
8.24
Face Value
1
Div. Yield
-
Book Value (TTM)
-
CASH
-
DEBT
-
EPS (TTM)
-
ROE
1.32
ROCE
-
Profit Growth
-
Listing Date
16-Jun-03
Promoter Holding
47.67%
FII Holding
15.9%
DII Holding
11.63%
Price Chart
Price Performance
1 Week2%
1 Month5%
3 Months12%
6 Months11%
1 Year13%
YTD6%
Moving Average
5 Day SMA1,006
10 Day SMA1,004
20 Day SMA982
30 Day SMA961
50 Day SMA915
61 Day SMA904
80 Day SMA912
200 Day SMA1,015
PIVOT LEVEL
| Standard | Camarilla | Fibonacci | Woodie's | |
|---|---|---|---|---|
| Resistance 3 | 1,089 | 1,024 | 1,052 | 1,092 |
| Resistance 2 | 1,052 | 1,018 | 1,029 | 1,054 |
| Resistance 1 | 1,030 | 1,013 | 1,015 | 1,033 |
| Pivot Point | 992 | 1,007 | 992 | 994 |
| Support 1 | 970 | 1,002 | 970 | 973 |
| Support 2 | 933 | 996 | 956 | 934 |
| Support 3 | 910 | 991 | 933 | 913 |
Competitors/Peers
| # | Symbol | MCAP | LTP | 1W | 1M | 6M | 1Y | P/E | Ind PE | Debt/Eq | Div Yld % | NP Qtr Rs.Cr. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SUNPHARMA | 4,42,187 | 1843 | 2% | 14% | 2% | 9% | 39 | 0 | 0 | 0 | |
| 2 | DIVISLAB | 1,80,280 | 6791 | 2% | 6% | 4% | 1% | 65 | 0 | 0 | 0 | |
| 3 | TORNTPHARM | 1,53,281 | 4529 | 0% | 8% | 18% | 40% | 64 | 0 | 0 | 0 | |
| 4 | APOLLOHOSP | 1,19,047 | 8280 | 3% | 7% | 12% | 17% | 58 | 0 | 0 | 0 | |
| 5 | CIPLA | 1,14,869 | 1422 | 1% | 10% | 7% | 4% | 22 | 0 | 0 | 0 | |
| 6 | DRREDDY | 1,11,015 | 1330 | 0% | 1% | 7% | 7% | 20 | 0 | 0 | 0 | |
| 7 | ZYDUSLIFE | 1,09,378 | 1087 | 6% | 16% | 15% | 17% | 20 | 0 | 0 | 0 | |
| 8 | LUPIN | 1,04,017 | 2275 | 1% | 2% | 9% | 15% | 23 | 0 | 0 | 0 | |
| 9 | MANKIND | 1,00,482 | 2434 | 3% | 7% | 7% | 2% | 49 | 0 | 0 | 0 | |
| 10 | MAXHEALTH | 96,867 | 995 | 7% | 1% | 15% | 14% | 0 | 0 | 0 | 0 | |
| Load More | ||||||||||||
Quarterly Results
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2290 | 2122 | 1966 | 1901 | 1929 | 1822 | 1752 | 1732 | 1759 | 1677 | 1680 | 1587 | 1678 | 1552 | 1600 | 1452 | 1528 | 1311 | 1657 | 1635 |
| Expenses | 1951 | 1833 | 1625 | 1611 | 1584 | 1535 | 1463 | 1480 | 1487 | 1459 | 1438 | 1419 | 1459 | 1408 | 1384 | 1259 | 1280 | 1116 | 1319 | 1269 |
| Operating Profit | 339 | 289 | 341 | 290 | 345 | 287 | 289 | 252 | 271 | 218 | 242 | 168 | 219 | 144 | 216 | 192 | 247 | 194 | 338 | 365 |
| OPM % | 15 | 14 | 17 | 15 | 18 | 16 | 17 | 15 | 15 | 13 | 14 | 11 | 13 | 9 | 14 | 13 | 16 | 15 | 20 | 22 |
| Other Income | 10 | -19 | 4 | 12 | 9 | -10 | 8 | 410 | -151 | 49 | 19 | 9 | 21 | 10 | -44 | 11 | -2 | 6 | 4 | 4 |
| Interest | 56 | 56 | 50 | 49 | 53 | 56 | 61 | 71 | 73 | 71 | 66 | 62 | 56 | 51 | 42 | 40 | 40 | 37 | 35 | 35 |
| Depreciation | 117 | 121 | 105 | 98 | 95 | 91 | 91 | 91 | 101 | 95 | 97 | 90 | 271 | 94 | 94 | 95 | 101 | 93 | 100 | 88 |
| Profit before tax | 176 | 93 | 190 | 154 | 206 | 130 | 144 | 500 | -54 | 101 | 98 | 25 | -86 | 9 | 36 | 69 | 106 | 70 | 208 | 247 |
| Tax % | 32 | 40 | 37 | 34 | 27 | 23 | 29 | 4 | 15 | 34 | 37 | 76 | 16 | 285 | 87 | 32 | 44 | 28 | 31 | 35 |
| Net Profit | 119 | 56 | 120 | 102 | 151 | 101 | 102 | 482 | -62 | 66 | 62 | 6 | -100 | -16 | 5 | 47 | 59 | 51 | 143 | 160 |
| EPS in Rs | 7.5 | 3.51 | 7.55 | 6.46 | 9.64 | 6.33 | 6.45 | 30.26 | -3.68 | 4.19 | 3.92 | 0.4 | -6.15 | -0.98 | 0.34 | 2.96 | 3.74 | 3.2 | 8.97 | 10.08 |
Profit and Loss
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8280 | 7234 | 6703 | 6282 | 6130 | 6099 | 5976 | 9111 | 7518 | 5861 | 5749 | 5751 | 5762 | 5132 |
| Expenses | 7020 | 6061 | 5802 | 5503 | 4980 | 4695 | 4428 | 7367 | 5995 | 4510 | 4493 | 5141 | 4763 | 4134 |
| Operating Profit | 1260 | 1173 | 901 | 779 | 1150 | 1403 | 1548 | 1744 | 1522 | 1352 | 1256 | 610 | 999 | 999 |
| OPM % | 15 | 16 | 13 | 12 | 19 | 23 | 26 | 19 | 20 | 23 | 22 | 11 | 17 | 19 |
| Other Income | 7 | 416 | -76 | -9 | 8 | 263 | 225 | -249 | 36 | 19 | 4 | 86 | -173 | -93 |
| Interest | 212 | 240 | 272 | 188 | 145 | 184 | 200 | 220 | 284 | 341 | 371 | 368 | 337 | 311 |
| Depreciation | 440 | 369 | 382 | 554 | 382 | 349 | 340 | 371 | 415 | 291 | 347 | 288 | 281 | 254 |
| Profit before tax | 614 | 981 | 170 | 28 | 630 | 1133 | 1233 | 904 | 859 | 738 | 542 | 40 | 207 | 341 |
| Tax % | 35 | 15 | 57 | 333 | 34 | 26 | 27 | 36 | 26 | 22 | 29 | 200 | 34 | 45 |
| Net Profit | 398 | 836 | 73 | -65 | 413 | 836 | 898 | 577 | 634 | 575 | 387 | -40 | 138 | 189 |
| EPS in Rs | 25.02 | 52.69 | 4.84 | -3.83 | 25.98 | 52.47 | 56.39 | 36.06 | 40.35 | 36.14 | 24.6 | -3.63 | 6.84 | 9.59 |
| Dividend Payout % | 20 | 9 | 102 | -130 | 19 | 10 | 9 | 12 | 7 | 8 | 12 | -83 | 43 | 31 |
Cash Flows
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0 | 1072 | 971 | 661 | 838 | 1784 | 1543 | 1122 | 1303 | 1268 | 1099 | 783 | 772 | 970 |
| Cash from Investing Activity | 0 | 512 | -596 | -474 | -323 | -727 | -267 | -1018 | -614 | -465 | -309 | -362 | -164 | -504 |
| Cash from Financing Activity | 0 | -1453 | -432 | -157 | -33 | -1709 | -1050 | 657 | -901 | -686 | -843 | -503 | -414 | -450 |
| Net Cash Flow | 0 | 132 | -58 | 30 | 482 | -652 | 225 | 761 | -212 | 117 | -52 | -82 | 194 | 17 |
Balance Sheet
| Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 15 | 16 |
| Reserves | 7077 | 6576 | 6239 | 5925 | 5418 | 5383 | 5303 | 4726 | 5588 | 4793 | 4071 | 3420 | 2951 | 2438 | 2611 | 2460 |
| Borrowings | 3615 | 2883 | 2731 | 3080 | 3664 | 3677 | 3192 | 2830 | 4808 | 4840 | 3469 | 4045 | 4493 | 4793 | 4395 | 4245 |
| Other Liabilities | 4815 | 4047 | 3598 | 2904 | 2240 | 1853 | 1319 | 1192 | 1898 | 1670 | 1902 | 1417 | 1280 | 1372 | 1842 | 1650 |
| Total Liabilities | 15523 | 13521 | 12584 | 11924 | 11338 | 10929 | 9830 | 8763 | 12310 | 11319 | 9457 | 8899 | 8740 | 8619 | 8864 | 8371 |
| Fixed Assets | 8044 | 7354 | 5176 | 5962 | 5091 | 5183 | 4871 | 4609 | 6340 | 5648 | 5401 | 5107 | 5104 | 4911 | 5099 | 4967 |
| CWIP | 2962 | 2344 | 3630 | 1857 | 2103 | 1562 | 1090 | 897 | 768 | 901 | 671 | 684 | 611 | 597 | 472 | 437 |
| Investments | 61 | 45 | 44 | 42 | 42 | 256 | 239 | 241 | 69 | 115 | 124 | 103 | 85 | 40 | 34 | 26 |
| Other Assets | 4455 | 3778 | 3735 | 4063 | 4101 | 3928 | 3631 | 3017 | 5133 | 4654 | 3262 | 3006 | 2939 | 3071 | 3259 | 2941 |
| Total Assets | 15523 | 13521 | 12584 | 11924 | 11338 | 10929 | 9830 | 8763 | 12310 | 11319 | 9457 | 8899 | 8740 | 8619 | 8864 | 8371 |
Delivery
| # | Date | 800 29% 1032 Value (Cr) | Q/T | 13 Del | 44 Del | 13 1 | 27-May | 992 | 6 | 11 | 50 | 3 | 2 | 26-May | 985 | 11 | 11 | 46 | 5 | 3 | 25-May | 1007 | 36 | 15 | 32 | 12 | 4 | 22-May | 1006 | 54 | 16 | 18 | 10 | 5 | 21-May | 1012 | 9 | 6 | 46 | 4 | 6 | 20-May | 1014 | 8 | 11 | 71 | 6 | 7 | 19-May | 1011 | 27 | 21 | 64 | 17 | 8 | 18-May | 1010 | 12 | 11 | 52 | 6 | 9 | 15-May | 990 | 5 | 6 | 46 | 2 | 10 | 14-May | 1004 | 10 | 10 | 44 | 4 | 11 | 13-May | 995 | 11 | 12 | 52 | 6 | 12 | 12-May | 988 | 10 | 11 | 43 | 4 | 13 | 11-May | 998 | 25 | 13 | 48 | 12 | 14 | 8-May | 1008 | 14 | 12 | 40 | 6 | 15 | 7-May | 981 | 15 | 15 | 57 | 9 | 16 | 6-May | 956 | 8 | 11 | 61 | 5 | 17 | 5-May | 940 | 6 | 9 | 60 | 4 | 18 | 4-May | 931 | 6 | 10 | 60 | 3 | 19 | 30-Apr | 927 | 6 | 14 | 59 | 4 | 20 | 29-Apr | 927 | 18 | 18 | 67 | 12 | 21 | 28-Apr | 942 | 14 | 12 | 45 | 6 | 22 | 27-Apr | 955 | 9 | 12 | 55 | 5 | 23 | 24-Apr | 945 | 10 | 11 | 56 | 5 | 24 | 23-Apr | 945 | 16 | 12 | 47 | 7 | 25 | 22-Apr | 928 | 8 | 8 | 58 | 5 | 26 | 21-Apr | 907 | 3 | 7 | 49 | 1 | 27 | 20-Apr | 906 | 7 | 10 | 60 | 4 | 28 | 17-Apr | 911 | 6 | 10 | 54 | 3 | 29 | 16-Apr | 907 | 10 | 10 | 52 | 5 | 30 | 15-Apr | 907 | 10 | 11 | 55 | 5 | 31 | 13-Apr | 892 | 5 | 9 | 48 | 2 | 32 | 10-Apr | 891 | 15 | 18 | 63 | 9 | 33 | 9-Apr | 879 | 23 | 11 | 36 | 9 | 34 | 8-Apr | 878 | 20 | 20 | 60 | 12 | 35 | 7-Apr | 869 | 32 | 13 | 49 | 16 | 36 | 6-Apr | 854 | 22 | 19 | 68 | 15 | 37 | 2-Apr | 839 | 17 | 19 | 62 | 11 | 38 | 1-Apr | 817 | 16 | 14 | 54 | 9 | 39 | 30-Mar | 816 | 37 | 14 | 65 | 24 | 40 | 27-Mar | 844 | 27 | 13 | 51 | 14 | 41 | 25-Mar | 860 | 12 | 8 | 44 | 5 | 42 | 24-Mar | 860 | 32 | 13 | 22 | 7 | 43 | 23-Mar | 816 | 14 | 10 | 63 | 9 | 44 | 20-Mar | 831 | 8 | 9 | 55 | 4 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Daily Market Cap
| Date | Total Market Cap | Change | Chg % |
|---|---|---|---|
| 28-May | 15,771c | 41c | 0.26 |
| 27-May | 15,730c | 96c | 0.60 |
| 26-May | 15,825c | 103c | 0.65 |
| 25-May | 15,928c | 245c | 1.51 |
| 22-May | 16,173c | 204c | 1.28 |
| 21-May | 15,969c | 284c | 1.75 |
| 20-May | 16,253c | 198c | 1.23 |
| 19-May | 16,056c | 191c | 1.20 |
| 18-May | 15,864c | 175c | 1.12 |
| 15-May | 15,689c | 237c | 1.49 |
| 14-May | 15,926c | 348c | 2.23 |
| 13-May | 15,578c | 131c | 0.83 |
| 12-May | 15,708c | 172c | 1.08 |
| 11-May | 15,880c | 234c | 1.50 |
| 07-May | 15,646c | 475c | 3.13 |
| 06-May | 15,172c | 199c | 1.33 |
| 05-May | 14,972c | 68c | 0.45 |
| 04-May | 14,905c | 102c | 0.69 |
| 30-Apr | 14,803c | 29c | 0.19 |
| 29-Apr | 14,774c | 277c | 1.84 |
| 28-Apr | 15,051c | 161c | 1.06 |
| 24-Apr | 15,212c | 140c | 0.93 |
| 23-Apr | 15,072c | 260c | 1.75 |
| 22-Apr | 14,812c | 318c | 2.19 |
| 21-Apr | 14,495c | 56c | 0.38 |
| 20-Apr | 14,550c | 24c | 0.16 |
| 17-Apr | 14,574c | 298c | 2.09 |
| 16-Apr | 14,276c | 136c | 0.94 |
| 15-Apr | 14,413c | 0 | 0 |
Stock Checklist
Price is below from 52 week high low average: 12%
Stock is trading above all short term SMAs: YES
Stock is trading above all long term SMAs: NO
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: NO
Promoters are buying the stock: NO